DMK Pharmaceuticals Corporation

DMKPQ · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$1,081$23,251$6,749$8,811
Short-Term Investments$30$0$0$0
Receivables$1,085$5,900$242$1,878
Inventory$1,239$419$1,227$2,061
Other Curr. Assets$5,837$5,634$4,306$1,127
Total Curr. Assets$9,272$35,204$12,524$13,877
Property Plant & Equip (Net)$1,607$2,985$3,468$13,541
Goodwill$0$0$868$7,641
Intangibles$0$0$6,290$11,128
Long-Term Investments$0$0-$7,573-$3,232
Tax Assets$0$0$415$1,432
Other NC Assets$52$109$14,875$3,455
Total NC Assets$1,659$3,094$18,343$33,964
Other Assets$0$0$0$0
Total Assets$10,931$38,298$30,867$47,841
Liabilities
Payables$7,937$3,754$1,780$4,268
Short-Term Debt$343$700$2,626$2,598
Tax Payable$0$0$1$4
Deferred Revenue$28$100$100$116
Other Curr. Liab.$3,088$6,669$15,418$2,425
Total Curr. Liab.$11,396$11,223$19,926$9,410
LT Debt$0$343$1,584$1,481
Deferred Rev, NC$178$750$850$800
Deferred Tax Liab, NC$0$0$528$113
Other NC Liab.$7$100$4,483$3,036
Total NC Liab.$186$1,192$7,444$5,430
Other Liabilities$0$0$0$0
Cap. Leases$343$692$1,018$1,926
Total Liabilities$11,582$12,415$27,370$14,839
Equity
Pref Stock$157$0$0$0
Common Stock$15$15$9$6
Retained Earnings-$304,564-$278,086-$229,912-$180,521
AOCI$0$0$0$0
Other Equity$303,741$303,954$233,400$213,516
Total Equity-$651$25,883$3,498$33,001
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,931$38,298$30,867$47,841
Net Debt-$739-$22,208-$2,539-$4,732